The LUCC-Blood network is one of the largest cancer research areas at Lund University. LUCC-Blood comprises over 20 research groups, which are mostly located in Lund. The scientific focus areas span from basic science to clinical studies, with major research projects within stem cell biology, genomics, genetics, cell signaling, biomarkers, tumor microenvironment, immunology, diagnostics, epidemiology, and anti-cancer therapies.

Blood cancer research at Lund University is world-renown for its high-quality basic and translational research and long-standing expertise in clinical trials, high-throughput methods, and functional in-vivo model systems. Some of the main research questions that blood cancer researchers at Lund University are trying to address include the origin of hematopoietic malignancies and their microenvironment, genetic predisposition and markers of disease diagnosis and progression, as well as the development of novel gene- and blood cell-based anti-cancer immune therapies.

The purpose of the LUCC-Blood network is to:

• provide a platform for our blood cancer researchers to meet and connect. This will lead to an active exchange of ideas and technologies and increased collaboration. 
• The ultimate goal, of course, is to improve the outcomes and quality of life of patients with malignant diseases of the hematopoietic system.

The LUCC-Blood network organizes regular seminars, symposia, invite speakers, and coordinate other scientific activities (see LUCC calendar). To learn more, contact the co-leaders Anna or Stefan.